QIAGEN launches unique CALR mutation assay for MPN diagnosis
QIAGEN today announced the European launch of a unique CE-IVD marked calreticulin (CALR) mutation assay to aid in establ…
QIAGEN today announced the European launch of a unique CE-IVD marked calreticulin (CALR) mutation assay to aid in establ…
. - AOP Orphan announces progress of pan-European phase III trial PROUD-PV to support European Marketing Authorization…
. - AOP Orphan announces results from phase II trial in PV at ASH Annual Meeting in Atlanta, U.S.A. - Promising effic…